Procoagulant in vitro effects of clinical cellular therapeutics in a severely injured trauma population

Clinical trials in trauma populations are exploring the use of clinical cellular therapeutics (CCTs) like human mesenchymal stromal cells (MSC) and mononuclear cells (MNC). Recent studies demonstrate a procoagulant effect of these CCTs related to their expression of tissue factor (TF). We sought to...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Stem Cells Transl Med
Main Authors: George, Mitchell J., Prabhakara, Karthik, Toledano‐Furman, Naama E., Gill, Brijesh S., Wade, Charles E., Cotton, Bryan A., Cap, Andrew P., Olson, Scott D., Cox, Charles S.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Inc. 2020
Assuntos:
Standards, Protocols, Policies, and Regulations for Cell‐based Therapies
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7103617/
https://ncbi.nlm.nih.gov/pubmed/31903737
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/sctm.19-0206
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados